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ABSTRACT
Introduction: An acute exacerbation of chronic
obstructive pulmonary disease (COPD) marks a critical
life event, which can lower patient quality of life and
ability to perform daily activities. Patients with COPD
tend to lead inactive and highly sedentary lifestyles,
which may contribute to reductions in functional
capacity. Targeting sedentary behaviour (SB) may be
more attainable than exercise (at a moderate-to-
vigorous intensity) for behaviour change in patients
following an exacerbation. This study aims to evaluate
the feasibility and acceptability of a 2-week at-home
intervention providing education and self-monitoring to
reduce prolonged periods of SB in patients with COPD
discharged following an acute exacerbation.
Methods and analysis: Patients will be randomised
into 1 of 3 conditions: usual care (control), education or
education+feedback. The education group will receive
information and suggestions about reducing long
periods of sitting. The education+feedback group will
receive real-time feedback on their sitting time, stand-
ups and step count at home through an inclinometer
linked to a smart device app. The inclinometer will also
provide vibration prompts to encourage movement when
the wearer has been sedentary for too long. Data will be
collected during hospital admission and 2 weeks after
discharge. Qualitative interviews will be conducted with
patients in the intervention groups to explore patient
experiences. Interviews with healthcare staff will also be
conducted. All data will be collected January to August
2016. The primary outcomes are feasibility and
acceptability, which will be assessed by qualitative
interviews, uptake and drop-out rates, reasons for
refusing the intervention, compliance, app usage and
response to vibration prompts.
Ethics and dissemination: The research ethics
committee East Midlands Leicester-Central has provided
ethical approval for the conduct of this study. The
results of the study will be disseminated through
appropriate conference proceedings and peer-reviewed
journals.
Trial registration number: ISRCTN13790881;
Pre-results.
INTRODUCTION
Targeting increases in physical activity in
patients with chronic obstructive pulmonary
disease (COPD) has been the emphasis of a
large number of exercise training and behav-
iour change interventions for over a decade.1
Despite these considerable efforts, there has
been limited success.1 2 The lower levels of
physical activity coupled with the often fragile
physical and psychological health (eg, low exer-
cise capacity and low self-esteem) among
patients with COPD may make reducing seden-
tary behaviour (SB) a more suitable conduit
for behaviour change.3 4 SB is defined as ‘any
waking behaviour characterised by an energy
expenditure ≤1.5 metabolic equivalents while
in a sitting or reclining posture’.5 Patients with
COPD demonstrate significantly higher levels
of SB compared with healthy controls.6
Strengths and limitations of this study
▪ The study will target a critical period for behav-
iour change in a clinical population admitted to
hospital.
▪ Important insights into the suitability of focus-
sing on sedentary behaviour (SB) using novel
wearable technology will be obtained.
▪ Given the timing of the intervention, it will not be
possible to obtain an objective assessment of
habitual physical activity or SB prior to hospital
admission.
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An acute exacerbation of COPD marks a critical life
event, characterised by a worsening of symptoms beyond
normal day-to-day variation; bringing with it a plethora of
negative impacts affecting both physical and psychological
health.7 For example, exacerbations contribute to reduc-
tions in patients’ abilities to perform activities of daily
living.8 For patients hospitalised for an acute exacerbation
of COPD, there is amplitude attention at the initial phase
of admission followed by ∼7 days of monitored inactivity
and sedentariness.9 Consequently, patients may be dis-
charged less well equipped to manage their ‘usual
routine’ than when they were admitted.9 Interventions
for patients with COPD in close temporal proximity to
hospital admissions are promising, with pulmonary
rehabilitation within 4 weeks postdischarge, found to
reduce rehospitalisation in the preceding 3 months.10
Despite this, postdischarge pulmonary rehabilitation is
sparsely taken up by patients who are offered it at the
point of discharge.11 A stepping stone approach which
does not emphasise exercise and does not require travel
and additional time/appointments may serve to facilitate
the physical and psychological well-being required for
patients to invest in pulmonary rehabilitation. To date,
few studies have specifically targeted non-rehabilitation
physical activity or SB immediately after discharge. There
is a need to determine the feasibility and acceptance of
such programmes, the evaluation of which may be
enhanced through qualitative approaches. Such an
approach may even offer as an alternative for those
patients unable to exercise at sufficient capacity to reduce
readmission risk.12
The time between hospital discharge and the initiation
of pulmonary rehabilitation (for those who attend)
marks an important period for patients. Pitta et al13 high-
lighted that patients with low activity levels at 1 month
after discharge were more likely to be readmitted within
the following year. Therefore, there is a need for behav-
ioural interventions for patients on leaving the hospital in
order to prevent further decline in quality of life, func-
tional capacity and potentially encourage uptake of pul-
monary rehabilitation. Owing to the impact of an acute
exacerbation (eg, dyspnoea and fatigue) interventions
requiring large amounts of effort or time may be imprac-
ticable.11 Consequently, targeting SB (eg, long periods of
consecutive sitting) during the early stages of post-
discharge recovery may act as a catalyst to encourage
patients to sit less and move more; equipping them with
the ethos and habits to better engage in pulmonary
rehabilitation when the time comes. Furthermore, target-
ing the displacement of SB with light activity such as
walking may help to reduce the risk of readmissions.14
Indeed, physical inactivity is widely regarded as the stron-
gest predictor of all-cause mortality in COPD15 and pre-
liminary evidence has suggested that a reduction in
sedentary time from discharge to 6 weeks will also help
reduce the risk of readmissions.16
Wearable technologies such as pedometers, which
provide a basis for self-monitoring and real-time
feedback, have been shown to elicit increases in physical
activity in patients with COPD.17 18 Patient-driven health-
care, facilitated by behavioural feedback and/or prompt-
ing, may empower patients to improve and track their
health outcomes.19 In a metaregression to identify the
active ingredients in activity promotion research, Michie
et al20 found self-monitoring and feedback to be among
the most potent behaviour change techniques. Coupling
behaviour change strategies such as self-monitoring and
feedback, which are grounded in control theory,21 tend
to have an impact greater than the sum of their inde-
pendent effects.20 As supported by a comprehensive
review of SB change strategies,22 providing patients with
education, self-monitoring, real-time feedback and
behaviour prompts may yield promising results.
However, in postexacerbation care for patients with
COPD, the use of wearable technology for behaviour
change has not been widely explored. Technology com-
petency and psychosocial issues in this population, par-
ticularly during phases of acute illness, makes examining
the uptake and engagement with such interventions fun-
damental to future success. The ‘Chronic Obstructive
Pulmonary Disease Sitting and ExacerbAtions Trial’
(COPD-SEAT) will focus on the feasibility of delivering a
home-based SB self-monitoring intervention in patients
following hospital discharge for an acute exacerbation.
The objectives of the trial are to:
1. Examine the feasibility of the ‘COPD-SEAT’ interven-
tion including the trial design, recruitment, adher-
ence and procedures.
2. Assess the acceptability of the intervention among
patients receiving the intervention and healthcare
staff involve in the care pathway.
3. Reduce prolonged periods of SB at home in patients
with COPD admitted for an acute exacerbation.
METHODS AND ANALYSIS
Trial design and registration
The feasibility study is a three-armed randomised con-
trolled trial (RCT) with 1:1:1 individual allocation com-
paring usual care (control) with usual care plus
education (education intervention) and usual care with
education plus feedback (education+feedback interven-
tion). The design of the study and flow of participants is
presented in figure 1.
This study will be conducted, analysed and reported
according to the Consolidation Standards of Reporting
Trials (CONSORT) statement for cluster RCTs.23 The
University Hospitals of Leicester will act as study
sponsor. The trial has been prospectively registered on
the ISRCTN website.
Participants
Eligibility criteria for patients
Patients eligible for inclusion in the study will be: aged
between 40 and 85 years; have a confirmed diagnosis of
COPD; have experienced fewer than four exacerbations
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requiring hospital admission in the previous 12 months;
have had a confirmed acute exacerbation as the reason
for current hospitalisation; willing and able to comply
with the trial protocol; are physically able to participate
in light intensity physical activity (ie, walking with an
aid); and able to provide informed consent (eg, read
and understand English).
Patients will be excluded if the COPD specialist nurses
or clinicians consider them unsuitable for the project
for any reason: for example, patients with severe mental
impairment or terminally ill; patients with an injury or
additional health condition that precludes their ability
to take part in light intensity physical activity; patients
with an overlying medical disorder that interferes with
provision of consent, completion of measurements,
intervention, interview or follow-up; and/or taking part
in concomitant research studies.
Setting
Participants will be recruited from patients admitted to
Glenfield Hospital, University Hospitals of Leicester
Figure 1 Flow of participants through the trial.
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NHS Trust for an acute exacerbation of COPD and will
be screened for eligibility by COPD specialist nurses.
Procedure
Eligible patients will be given a verbal description of the
study, participant information sheet and expression of
interest form by a researcher after they have received
usual care from a COPD specialist nurse. A researcher
will revisit the patients at the bedside at an agreed time
to collect the expression of interest form from the
patient. For those patients who are not interested in
taking part in the trial, reasons for this (if offered
freely) may be taken as field notes or by an interview if
patients consent to this. For patients wishing to take part
in the study, informed consent will be obtained followed
by prerandomised group allocation. If allocated to the
education or education+feedback group, patients will
then receive the respective intervention. Questionnaires,
activity monitor deployment and qualitative interview
(intervention groups only) will then be completed prior
to discharge. The timing of these procedures will vary
based on expected discharge. On discharge, patients will
wear the activity monitors for 2 weeks before returning
for their follow-up appointment.
Trial interventions
Control
Although there are some variations in practice, ‘usual
care’ offered to patients with COPD admitted to hospital
for an acute exacerbation typically comprises brief
advice to take part in regular exercise, information
about pulmonary rehabilitation, and a referral to a
follow-up clinic if the patient is eligible and does not
decline pulmonary rehabilitation during their admis-
sion. No in-hospital rehabilitation is conducted as part
of usual care. Patients also receive brief discussions and
advice regarding smoking cessation (if appropriate),
medication and inhaler techniques, and oxygen therapy
(if appropriate); generally lasting 15–30 min. All patients
will receive a phone call during the first week of dis-
charge, as per usual care. Patients will be provided with
a 24-hour number to call if they have any questions
during the course of their involvement in the trial.
Intervention
Education Written information will be provided by an
educational booklet, four pages in length, adapted for
patients with COPD from ‘On Your Feet to Earn Your
Seat’.24 The ‘On Your Feet to Earn Your Seat’ booklet
was originally developed in accordance with the habit
formation model25 26 and designed using a ‘small
changes’ approach as detailed by Gardner et al.24 This
booklet24 was modified to emphasise simpler behaviours,
in this case standing up from a chair, which may be
more appealing and attainable to patients with COPD
postexacerbation compared with more daunting beha-
viours such as stair climbing.25
The researcher will go through the revised booklet,
entitled ‘Sit Less, Move More, Live Healthier’, with the
patient at the bed-side outlining the importance of
breaking up long periods of sitting and discussing indivi-
dualised strategies and opportunities for the patient to
do this at home. This booklet contains seven sugges-
tions: leave the house daily; make ad breaks active; stand-
ups (eg, when waiting for a bus); tiptoe through the
queue; increase your steps, sit to stand with no hands
and treat the seat as a treat. For each of these tips,
‘handy-hints’ are provided to facilitate the adoption of
these small changes (eg, offering ways to incorporate
them into everyday life). The components of the educa-
tion delivery are presented in box 1. In addition to the
extensive focus groups and interviews for the original
booklet,24 the ‘Sit Less, Move More, Live Healthier’
booklet has been through our Pulmonary and Cardiac
Rehabilitation Patient and Public Involvement Advisory
group who provided feedback on content, readability
and design.
Education+feedback Patients randomised into the educa-
tion+feedback group will receive the above education
intervention (ie, ‘Sit Less, Move More, Live Healthier’
booklet) plus a wearable device to self-monitor their SB
and physical activity as well as provide a behavioural
nudge in the form of a vibration prompt. The wearable
provides real-time, visual and numeric feedback on time
spent sitting, standing and lying down, number of
sit-to-stand transitions and step count. It also allows the
user to look back at previous days, providing day-to-day
comparisons in the form of a bar chart.
Patients will be shown how to wear the device at the
bedside and will fit the monitor themselves to ensure
the device is correctly adjusted to ensure a secure and
snug fit. The device, LUMO (Lumo Bodytech, Palo Alto,
California, USA), is a small (4.15×10×0.8 cm; 25 g) and
flexible sensor (figure 2) which is worn around the
lower back on a belt. The sensor connects wirelessly via
low energy Bluetooth to a mobile application on a smart
device provided to patients. The embedded inertial
sensors of the LUMO continuously track the amount of
time spent lying down, slouching, sitting, standing and
transitioning from sitting to standing providing the
patients with up-to-date information of their behaviour
whenever they want it.
Patients will be trained while in hospital on how to
navigate the app (touch screen). Real-time feedback is
provided on a mobile app with panels displaying time
spent sitting (including proportions of time spend stand-
ing and stepping; figure 3A), sit-to-stand transitions
(figure 3B) and step count (figure 3C) using low cogni-
tive load graphics and data presented on a daily, weekly
and monthly format.
Additionally, the LUMO will alert the patient to break
up their sitting time when they have been sitting for ‘too
long’ via gentle vibration. After a full explanation of the
LUMO and app, patients will be asked how much con-
secutive sitting they would want to accumulate before
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being prompted (eg, every hour of continuous sitting).
The vibration frequency will be fixed for the 2-week dur-
ation. The components of the LUMO app and vibration
prompt delivery are shown in box 1.
Feasibility
Measures for assessing feasibility are provided in table 1
and will include: the number of patients eligible for the
study; the proportion of patients approached who agree
to participate; the duration of the intervention deliver-
ies; views of patients and healthcare staff on the timing
of the intervention; and the number of telephone
Box 1 Intervention components
▸ Education booklet: components to cover during intervention delivery
It will be explained that the booklet will provide information to help them to sit less and move more.
It will be explained that sitting for too long can be harmful to their health.
It will be explained that breaking up long periods of sitting can help reduce joint stiffness and pain.
The principle of ‘use it or lose it’ will be explained in relation to deconditioning.
If deemed appropriate, other tailored examples of benefits to be had will be explained.
The patient will be directed to the 7 suggestions for an active recovery.
If deemed appropriate the first suggestion (leave the house daily) will be discussed.
If deemed appropriate the second suggestion (make TV advert breaks active) will be discussed.
If deemed appropriate the third suggestion (stand up when waiting for something) will be discussed.
If deemed appropriate the fourth suggestion (tiptoe when waiting in a queue) will be discussed.
If deemed appropriate the fifth suggestion (increase your steps) will be discussed.
If deemed appropriate the sixth suggestion (sit to stand with no hands) will be discussed.
If deemed appropriate the seventh suggestion (treat the seat as a treat) will be discussed.
If deemed appropriate additional tailored top tip examples will be discussed.
▸ Smart device: components to cover during intervention delivery
It will be explained that the LUMO and smart device communicate with each other automatically.
Patients will learn how to lock and unlock the smart device.
▸ LUMO app: components to cover during intervention delivery
It will be explained that the app provides the patient with information on sitting, standing and stepping.
Patients will be shown where to find their time spent sitting ‘today’ on the app home screen.
Patients will be shown where to find how many time they have stood up ‘today’ on the app home screen.
Patients will be shown where to find their step count ‘today’ on the app home screen.
▸ Sit time panel: components to cover during intervention delivery
Patients will be shown how to access the pie chart for time sitting, standing, stepping and lying down.
Patients will be shown the hourly bar chart for all behaviours.
Patients will be shown how to look back at previous days.
Patients will be shown how to return to ‘today’s’ information.
Patients will be shown how to return to the home screen.
▸ Stand ups panel: components to cover during intervention delivery
Patients will be shown the hourly bar chart for all behaviours.
Patients will be shown how to look back at previous days.
Patients will be shown how to return to ‘today’s’ information.
Patients will be shown how to return to the home screen.
▸ Steps panel: components to cover during intervention delivery
Patients will be shown the hourly bar chart for all behaviours.
Patients will be shown how to look back at previous days.
Patients will be shown how to return to ‘today’s’ information.
Patients will be shown how to return to the home screen.
▸ Vibration prompt: components to cover during intervention delivery
It will be explained that the LUMO device provides a vibration prompt when they have sat for ‘too long’.
It will be explained that the vibration will only go off once then the timer will reset.
Patients will choose the duration of consecutive sitting before the vibration occurs.
Figure 2 The LUMO sensor.
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contacts and duration of phone calls with patients
during follow-up beyond usual care.
Acceptability
To the patients (education and education+feedback
groups only):
A. Patients’ experience of the educational intervention
in the context of their daily lives and health
explored in qualitative interviews (eg, how they
found the booklet, eg, did they read or recall it,
what aspects they perceived as useful, and how/why
and in what contexts they reduced/did not reduce
SB, how the intervention could be improved).
B. Proportion of patients who stopped wearing the
device during the 2 weeks of follow-up; when they
did this (eg, number of days into the follow-up) and
why they stopped (assessed during interviews).
C. Proportion of patients who attended the follow-up
appointment and reasons why patients did not com-
plete the study (assessed by telephone interview).
To the patients (education+feedback group only):
A. Patients’ experience of the LUMO device, mobile
application and vibration prompts in the context of
their daily lives and health will be explored in the
interviews (eg, how they found using the device,
their perspectives on the feedback and prompts; how
they reduced SB using the device, or why or in what
contexts they did not reduce SB, how the technology
and feedback could be improved).
B. Patients’ response to the vibration prompts, as exam-
ined by LUMO data (eg, number of vibrations;
average response time from vibration to stand-up;
number of times the vibration prompt resulted in
behaviour change).
C. Patients’ use of the LUMO mobile application, as
examined using Flurry app analytics (eg, time spent
on the app; time spent in each feedback panel of the
app; number of sessions; duration of sessions).
Intervention fidelity
Examining intervention fidelity may help to explain vari-
ance in outcomes (eg, wearing the activity monitors)
related to non-adherence or partial adherence to the
intervention.27 For the education and education+feed-
back groups, researcher delivery of the intervention
(education booklet, LUMO app and vibration prompt)
will be audio recorded. The deliveries will be assessed
against a checklist of content designed specifically for
COPD-SEAT. For example, for the education group,
information about why it is important to reduce long
periods of sitting should be covered and examples of
how to do this discussed. For the education+feedback
group, a walk-through of the LUMO app should be con-
ducted with explanations of all information provided by
the app (eg, sitting time, stand-ups and step count).
This will provide a measure of how much of the inter-
vention was actually delivered to the patients.28 Each
component of the checklist will be subject to dichotom-
ous scales (present or absent) to determine consistency
of delivery and ordinal scales to determine quality of
delivery (none, adequate or excellent).
Data collection
Data will be collected January to August 2016 by trained
researchers, following standard operating procedures.
Researchers will not be blinded to treatment allocation
for qualitative interviews and study measurements.
Baseline data will be collected during patients’ hospital
stay. The timing of baseline data collection cannot be
standardised due to variation in the timing of patients
receiving usual care from COPD specialist nurses,
screening and length of stay.
Figure 3 LUMO app panels showing: (A) proportion of the day spent standing, stepping, sitting and lying down; (B) daily
number of sit-to-stand transitions; and (C) daily step count.
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Sample characteristics
Objectively measured physical activity and SB
Following hospital discharge (day 0), patients will be
asked to wear two monitors, one posture sensor (gyro-
scope) and one triaxial accelerometer, for 14 days and
return the devices at the follow-up appointment (day
15). An ActiGraph wGT3X-BT triaxial accelerometer will
be worn on a waistband (on the right anterior axillary
line) for 2 weeks to measure time spent in physical activ-
ity (ie, sedentary, light, moderate, and vigorous) using
common cut-points (eg, as published by Freedson
et al29) and step count. Patients will be asked to wear the
device during waking hours and to only remove it
during that period for water-based activities.
The LUMO posture sensor will serve to objectively
quantify SB in all groups (control, education and educa-
tion+feedback). Therefore, it will act as both the meas-
urement and intervention device for the education
+feedback group. In addition to physical activity intensity
data collected by the ActiGraph accelerometer, the
LUMO will provide information on sitting, driving,
lying, standing, sit-to-stand transitions and stepping. The
device will be worn on the lower back (in contact with
skin) for 2 weeks postdischarge. Patients will be asked to
wear the monitor during waking hours and to remove it
for water-based activities. The LUMO has been found to
produce valid measurements of free-living SB (mean
error of 9.5%)30 and step count (mean absolute per-
centage error 0.4%)31 compared with the ActivPAL
(PAL Technologies, Glasgow, UK). While no validation
study to date has specifically examined LUMO stand-ups,
valid free-living SB against the ActivPAL supports accur-
ate detection of sit-to-stand transitions. LUMO data will
be analysed in 5 min epochs with behaviours sum-
marised as a percentage of each 5 min epoch (eg, 50%
sitting will be converted to 2.5 min sitting).
Patients will be asked to wear for the ActiGraph and
LUMO monitors concomitantly for two main reasons.
First, as noted above, the LUMO monitor is a relatively
new device and has not yet been subject to multiple valid-
ation studies across different populations (eg, ages,
disease states and habitual activity levels). Therefore, the
Table 1 Outline of feasibility indicators
Indicators Data sources Timing
Recruitment
Feasibility of patient screening and recruitment Healthcare staff interviews, project records
(eg, number of eligible patients missed)
Ongoing throughout the
study
Number of eligible patients, number of patients
screened, number of patients invited to take part,
actual number of patients who consent to take
part
Medical records and project records Ongoing throughout the
study
Number of patients who refuse, drop out or opt
out
Patient requests, qualitative patient interviews,
field notes
Intervention delivery
Duration of intervention sessions (education and/
or device training); patient engagement in the
content
Audio recordings of the intervention sessions,
qualitative patient interviews
Ongoing throughout the
study
Description of unintended events
It is important to note whether there were any
unintended side effects or outcomes from the
intervention. For example, did patients start
doing one particular activity but at the expense of
another? Unexpected outcomes are not
necessarily negative. For example, there may be
unexpected positive health outcomes.
Qualitative patient interviews, medical notes 2-week follow-up
appointment
Hospital readmissions related to the study. For
example, trying to move more resulting in a fall
Medical notes Ongoing throughout the
study
Patient satisfaction, acceptability and enjoyment
Satisfaction/dissatisfaction with the intervention;
likes/dislikes; suggested improvements
Qualitative patient interviews conducted by
researcher with no involvement in intervention
delivery to encourage honest opinions and
feedback
2-week follow-up
appointment, analysis of
app usage
Potential sustainability
Whether healthcare staff could envision the
implementation of the intervention within routine
care and what they would alter
Qualitative interviews with healthcare staff Ongoing throughout the
study
The number of telephone contacts and duration
of telephone conversations with patients during
follow-up beyond usual care
Project records Ongoing throughout the
study
Orme M, et al. BMJ Open 2016;6:e013014. doi:10.1136/bmjopen-2016-013014 7
Open Access
group.bmj.com on October 13, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
ActiGraph provides a well-established measurement of
physical activity and sedentary time in COPD and general
populations. Second, it is unclear whether patients will
dislike the nudge/vibration feature of the LUMO and
thus remove it. Consequently there is a need for an inde-
pendent evaluation and intervention sensor.
Psychosocial health
During hospital stay and at follow-up a range of health/
psychosocial measures will be taken. COPD-specific
health status will be examined using the COPD
Assessment Test (CAT; eight items).32 Overall health
status will be assessed using the EuroQol (EQ-5D-5L; five
items).33 Additional symptom burdens will be assessed
by the Functional Assessment of Chronic Illness
Therapy-Fatigue (40 items; FACIT-F)34 and the Hospital
Anxiety and Depression Scale (HADS; 14 items).35 Fear
of falling will be assessed using the Falls Efficacy
Scale-International (FES-I; 16 items).36
Self-reported physical activity and sitting
During hospital stay patients’ usual time spent sitting in
domain-specific activities (TV, transport, work, computer
and other) during weekdays and weekend days will be
self-reported using an adapted version of the Marshall
Sitting Time Survey (10 items).37 Patients will be asked
to complete an adapted version of the International
Physical Activity Questionnaire (IPAQ) Short Form
(three items)38 to assess usual physical activity levels.
Usual dyspnoea severity
In order to examine patients’ usual breathlessness sever-
ity, that is, when not acutely ill, the modified Medical
Research Council (mMRC) dyspnoea scale (single
item)39 will be completed.
Body composition and physical function
At follow-up height, weight and waist circumference will
be measured to the nearest 0.1 cm, 0.1 kg and 0.1 cm,
respectively. Waist circumference will be measured twice,
with a third conducted if the difference between the
first two is >3 cm. Patients will also be asked to complete
the Short Physical Performance Battery (SPPB) which
comprises repeated chair stands; balance tests and a 4 m
walk.40 Upper body skeletal muscle assessment will be
grip strength using a hand-held dynamometer.
Sample size estimation and recruitment target
The study will aim to recruit as many patients as are
admitted to hospital for an acute COPD exacerbation
within the operational period. One of the main objec-
tives of this feasibility study is to provide data on eligibil-
ity and recruitment and to enable an accurate
estimation of the required sample size for a future trial
based on a realistic recruitment plan. The number of
hospital admissions for an acute exacerbation of COPD
is ∼80–100 patients per month and in a previous
in-hospital early rehabilitation trial conducted in part at
Glenfield Hospital, overall recruitment uptake was
32.3%.12 Therefore, a similar admissions rate and uptake
(∼1 in 3) would be expected for COPD-SEAT.
Randomisation
Block randomisation (1:1:1) will be used to ensure a
balance in sample size between the three study groups.
Balanced combinations of group allocations within
blocks will be conducted by a researcher at
Loughborough University who is independent of the
research team. This will ensure study team researchers
will be blinded to group allocation prior to patients
deciding whether to take part in the study. Owing to
limited study team members and logistical barriers,
study team researchers will be made aware of group allo-
cation before consent. Patients will only be informed of
their group allocation after providing informed consent.
Quantitative data analysis
As this is a feasibility study, it is not appropriate at this
stage to aim for sufficient statistical power to detect
changes over time or between group changes.
Therefore, quantitative data analysis will primarily be
descriptive; in the form of estimations of means and SDs
and proportions of patients screened, eligible and
willing to participate and complete the trial. In order to
examine differences in patient characteristics between
study groups, between-group comparisons will be
assessed using independent t-tests or analysis of variance
(ANOVA). Within-group comparisons will be conducted
using paired sample t-tests or repeated measures
ANOVA if data meet parametric assumptions.
Data will be entered and housed on a secure web-
based database system, Research Electronic Data
Capture (REDCap), which has discrepancy management
capabilities. Data will be transferred from REDCap to
the Statistical Package for the Social Sciences (SPSS) for
statistical analysis.
All participant information collected as part of the
research will be kept strictly confidential. With permis-
sion, patients’ general practitioner will be informed of
their participation in the study. Any information regard-
ing patients which leaves the hospital will have their
name and address removed. Participants will not be
identified in any subsequent written materials and
results will be reported in such a way that confidentiality
is preserved.
Qualitative research
The aim of the qualitative research is to identify poten-
tial barriers and facilitators to participation in the trial
and in the self-monitoring and education programme.
This information will help maximise chances of avoiding
recruitment and retention issues and facilitate optimal
qualitative process evaluation of the eventual trial.
Patients randomised to the education or education
+feedback intervention groups will be invited to take part
in two semistructured interviews. The first interview will
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take place at the bedside before being discharged from
hospital and will explore areas including perceptions of
SB in general and in relation to managing COPD, previ-
ous experiences of using technology, previous experi-
ences of advice about COPD self-management as well as
their study expectations. The second interview will take
place at the 2-week follow-up appointment. These inter-
views will explore the overall acceptability and experi-
ences of the educational and self-monitoring
interventions, how the interventions are perceived and
how they fit into the daily life and health context of the
participants, participants’ perspectives on the recruit-
ment process, context and time (ie, following exacerba-
tion) of the intervention (both education and education
+feedback) and specific components of the intervention
(eg, prompts). Patients, who do not attend their
follow-up appointment, will be invited for a telephone
interview to explore reasons for not completing the study.
It is not only important to understand reasons for par-
ticipant engagement with an intervention but also
reasons for non-engagement. For patients who are
offered the intervention but who do not take part in the
main trial, reasons for not wanting to engage with the
study will be noted as part of field notes or qualitative
refusal interviews where patients consent to this.
Given the timing and setting of the trial (in-hospital
and immediately after discharge) qualitative interviews
with healthcare staff within the care pathway of hospita-
lised patients with COPD (eg, clinicians, COPD specialist
nurses and ward nurses) will be conducted to explore
topics, such as perspectives on the feasibility of reducing
SB in this population and in the hospital setting and the
use of self-monitoring technology to achieve this. All
interviews will be conducted by a social scientist with
experience in conducting qualitative research.
Qualitative data analysis
The qualitative interviews will be recorded, transcribed
and analysed using thematic analysis. The approach
identifies emerging, recurrent themes or patterns in the
interviews.41 In the context of this feasibility study, quali-
tative analysis will mean identifying emergent themes to
highlight features of the study, intervention and partici-
pants’ context that facilitate or hinder their engagement
with the trial and the intervention.42
All qualitative interviews will be audio recorded (with
informed consent) and transcribed in verbatim.
Transcripts will be analysed using constant comparison,
which identifies recurrent themes in the interviews, ini-
tially using free coding and subsequently interrogating
emergent themes, particularly those pertaining (but not
limited) to the issues facilitating or hindering engage-
ment with the study and intervention.43 Following the
principles of thematic analysis, emergent themes will be
identified and probed throughout the study, so that the
interview schedule and coding schedule are modified to
follow new leads until new themes no longer emerge.
Recruitment of participants will also continue until new
themes no longer emerge and the material begins to
cohere around key themes, that is, thematic saturation is
reached.43 The principle of the analysis is to create a
coding frame that ‘fits’ the data rather than trying to
make the data ‘fit’ a pre-existing coding frame to allow
examining issues around the intervention from a broad
contextual perspective.43
ETHICS AND DISSEMINATION
Findings from this feasibility study, particularly patient
preferences and acceptability, will inform the design of
any subsequent RCT. The primary outcome for future
efficacy trials will be readmission rates. Beyond this, we
will seek to implement the findings of the RCT into
routine care and locally we will share these results with
local secondary care interface groups such as service
managers. Results will be disseminated to our
Pulmonary and Cardiac Rehabilitation Patient and
Public Involvement Advisory group whose members are
current and former pulmonary and cardiac rehabilita-
tion patients or interested members of the public who
have participated in previous research trials. We have a
number of national and international visitors who come
to share our practice which we anticipate will stimulate
interest in the study findings. We will be able to use the
internet to widely publicise the findings of our work and
promote interest in the self-monitoring programme.
The results of this feasibility study will be presented to
participants of the feasibility study through a dedicated
dissemination evening; at appropriate national, inter-
national and regional respiratory, physiotherapy and
physical activity conferences; local study days in second-
ary care; and through peer-reviewed journals.
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